Drugs Made In America Acquisition Corp. (DMAA) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

31,208,043Shares Outstanding

9,528,480Shares held by institutions

$99,572,616Value of institutional holdings

72.54%Institutional ownership %

-4.84%Shares Changed QoQ

39No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

The institutional landscape for Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) includes 39 filers as of the latest reporting cycle ending December 2025.

Drugs Made In America Acquisition saw its institutional ownership percentage fell to 72.5% in December 2025 from 77.9% in September 2025.
On a quarter-over-quarter basis, institutional holdings shifted by -4.84%, with a year-over-year an unavailable change in the count of filers.
A review of institutional activity for Drugs Made In America Acquisition shows 15 of 39 filers increasing their positions, while 8 reduced their stake, and 16 remained unchanged.
The aggregate institutional position in Drugs Made In America Acquisition now stands at 22.64Mn shares as of December 2025, after investors decreased their holdings (down by 1.15Mn shares quarter on quarter which is down N/A shares year over year).
Karpus Management, Inc. continues to be the largest institutional holder of Drugs Made In America Acquisition as of December 31, 2025, with a position of 2.54Mn shares, representing 8.13% of the company's outstanding stock.
Among the most significant buyers of Drugs Made In America Acquisition during December 2025 were Mercuria Capital Strategies, LLC (750.00K), MIZUHO SECURITIES USA LLC (333.04K), Quarry LP (250.83K), Governors Lane LP (238.80K), L1 Global Manager Pty Ltd (200.00K).
Leading sellers of Drugs Made In America Acquisition stock in December 2025 included Polar Asset Management Partners Inc. (2.20Mn), HEIGHTS CAPITAL MANAGEMENT, INC (650.00K), TORONTO DOMINION BANK (250.00K), BOOTHBAY FUND MANAGEMENT, LLC (153.85K), JPMORGAN CHASE & CO (49.87K).
The top 10 institutional holders of Drugs Made In America Acquisition for the quarter ending December 2025 included Karpus Management, Inc. (2.54Mn), First Trust Capital Management L.P. (2.24Mn), GLAZER CAPITAL, LLC (1.82Mn), Westchester Capital Management, LLC (1.67Mn), Polar Asset Management Partners Inc. (1.60Mn), Hudson Bay Capital Management LP (1.55Mn), MIZUHO SECURITIES USA LLC (1.43Mn), WOLVERINE ASSET MANAGEMENT LLC (1.31Mn), ARISTEIA CAPITAL, L.L.C. (881.72K), Mercuria Capital Strategies, LLC (750.00K).

39 Institutional Holders

9,528,480 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
Karpus Management, Inc.	31 Dec, 2025	2,538,642	-9,025	-0.35%	$26,325,718.00
First Trust Capital Management L.P.	31 Dec, 2025	2,242,500	0	0.00%	$23,264,144.00
GLAZER CAPITAL, LLC	31 Dec, 2025	1,816,428	-5,864	-0.32%	$18,836.00
Westchester Capital Management, LLC	31 Dec, 2025	1,669,000	0	0.00%	$17,307,530.00
Polar Asset Management Partners Inc.	31 Dec, 2025	1,600,000	-2,200,000	-57.89%	$16,598,720.00
Hudson Bay Capital Management LP	31 Dec, 2025	1,550,000	0	0.00%	$16,073,500.00
MIZUHO SECURITIES USA LLC	31 Dec, 2025	1,433,483	333,036	30.26%	$14,771,165.00
WOLVERINE ASSET MANAGEMENT LLC	31 Dec, 2025	1,307,468	58,340	4.67%	$13,563,935.00
ARISTEIA CAPITAL, L.L.C.	31 Dec, 2025	881,716	0	0.00%	$9,147,098.00
Mercuria Capital Strategies, LLC	31 Dec, 2025	750,000	750,000	0.00%	$7,511,250.00
D. E. Shaw & Co., Inc.	31 Dec, 2025	690,000	0	0.00%	$7,155,300.00
HEIGHTS CAPITAL MANAGEMENT, INC	31 Dec, 2025	650,000	-650,000	-50.00%	$6,740,500.00
Radcliffe Capital Management, L.P.	31 Dec, 2025	546,808	18,708	3.54%	$5,673,133.00
LMR Partners LLP	31 Dec, 2025	500,000	0	0.00%	$5,187,100.00
J. Goldman & Co LP	31 Dec, 2025	500,000	0	0.00%	$5,187,100.00
RIVERNORTH CAPITAL MANAGEMENT, LLC	31 Dec, 2025	417,998	100,000	31.45%	$4,334,639.00
WHITEBOX ADVISORS LLC	31 Dec, 2025	400,000	0	0.00%	$4,149,680.00
AQR Arbitrage LLC	31 Dec, 2025	371,211	0	0.00%	$3,849,458.00
BOOTHBAY FUND MANAGEMENT, LLC	31 Dec, 2025	346,154	-153,846	-30.77%	$3,591,071.00
Clear Street Group Inc.	31 Dec, 2025	325,973	116,407	55.55%	$995,643.00

1 - 20 of 39

Research Tools